274 related articles for article (PubMed ID: 18801738)
21. Chemogenetics defines a short-chain fatty acid receptor gut-brain axis.
Barki N; Bolognini D; Börjesson U; Jenkins L; Riddell J; Hughes DI; Ulven T; Hudson BD; Ulven ER; Dekker N; Tobin AB; Milligan G
Elife; 2022 Mar; 11():. PubMed ID: 35229717
[TBL] [Abstract][Full Text] [Related]
22. Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.
Smith NJ; Ward RJ; Stoddart LA; Hudson BD; Kostenis E; Ulven T; Morris JC; Tränkle C; Tikhonova IG; Adams DR; Milligan G
Mol Pharmacol; 2011 Jul; 80(1):163-73. PubMed ID: 21498659
[TBL] [Abstract][Full Text] [Related]
23. Homology modeling of FFA2 identifies novel agonists that potentiate insulin secretion.
Villa SR; Mishra RK; Zapater JL; Priyadarshini M; Gilchrist A; Mancebo H; Schiltz GE; Layden BT
J Investig Med; 2017 Dec; 65(8):1116-1124. PubMed ID: 28784695
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for the ligand recognition and signaling of free fatty acid receptors.
Zhang X; Guseinov AA; Jenkins L; Li K; Tikhonova IG; Milligan G; Zhang C
Sci Adv; 2024 Jan; 10(2):eadj2384. PubMed ID: 38198545
[TBL] [Abstract][Full Text] [Related]
25. β-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3.
Won YJ; Lu VB; Puhl HL; Ikeda SR
J Neurosci; 2013 Dec; 33(49):19314-25. PubMed ID: 24305827
[TBL] [Abstract][Full Text] [Related]
26. FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells.
Lorza-Gil E; Kaiser G; Rexen Ulven E; König GM; Gerst F; Oquendo MB; Birkenfeld AL; Häring HU; Kostenis E; Ulven T; Ullrich S
Sci Rep; 2020 Oct; 10(1):16497. PubMed ID: 33020504
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes.
Wang A; Gu Z; Heid B; Akers RM; Jiang H
J Dairy Sci; 2009 Jun; 92(6):2696-705. PubMed ID: 19448003
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of the free fatty acid receptor 2 (FFA2) and a novel functional FFA2-like receptor (FFA2L) for short-chain fatty acids in pigs: evidence for the existence of a duplicated FFA2 gene (FFA2L) in some mammalian species.
Zhang J; Cheng S; Wang Y; Yu X; Li J
Domest Anim Endocrinol; 2014 Apr; 47():108-18.e1. PubMed ID: 24315753
[TBL] [Abstract][Full Text] [Related]
29. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions.
Stoddart LA; Smith NJ; Milligan G
Pharmacol Rev; 2008 Dec; 60(4):405-17. PubMed ID: 19047536
[TBL] [Abstract][Full Text] [Related]
30. FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.
Ang Z; Xiong D; Wu M; Ding JL
FASEB J; 2018 Jan; 32(1):289-303. PubMed ID: 28883043
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.
Le Poul E; Loison C; Struyf S; Springael JY; Lannoy V; Decobecq ME; Brezillon S; Dupriez V; Vassart G; Van Damme J; Parmentier M; Detheux M
J Biol Chem; 2003 Jul; 278(28):25481-9. PubMed ID: 12711604
[TBL] [Abstract][Full Text] [Related]
32. Short-chain free-fatty acid G protein-coupled receptors in colon cancer.
Moniri NH; Farah Q
Biochem Pharmacol; 2021 Apr; 186():114483. PubMed ID: 33631190
[TBL] [Abstract][Full Text] [Related]
33. Chemogenetic Approaches to Explore the Functions of Free Fatty Acid Receptor 2.
Milligan G; Barki N; Tobin AB
Trends Pharmacol Sci; 2021 Mar; 42(3):191-202. PubMed ID: 33495026
[TBL] [Abstract][Full Text] [Related]
34. Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.
Hopkins MM; Meier KE
Handb Exp Pharmacol; 2017; 236():233-251. PubMed ID: 27757756
[TBL] [Abstract][Full Text] [Related]
35. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.
Tang C; Ahmed K; Gille A; Lu S; Gröne HJ; Tunaru S; Offermanns S
Nat Med; 2015 Feb; 21(2):173-7. PubMed ID: 25581519
[TBL] [Abstract][Full Text] [Related]
36. Free fatty acid receptor 3 is a key target of short chain fatty acid. What is the impact on the sympathetic nervous system?
López Soto EJ; Gambino LO; Mustafá ER
Channels (Austin); 2014; 8(3):169-71. PubMed ID: 24762451
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for the ligand recognition and signaling of free fatty acid receptors.
Zhang X; Guseinov AA; Jenkins L; Li K; Tikhonova IG; Milligan G; Zhang C
bioRxiv; 2023 Aug; ():. PubMed ID: 37662198
[TBL] [Abstract][Full Text] [Related]
38. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of G-protein coupled receptor--FFA2.
Swaminath G; Jaeckel P; Guo Q; Cardozo M; Weiszmann J; Lindberg R; Wang Y; Schwandner R; Li Y
Biochem Biophys Res Commun; 2011 Feb; 405(1):122-7. PubMed ID: 21216233
[TBL] [Abstract][Full Text] [Related]
40. Role of free fatty acid receptors in the regulation of energy metabolism.
Hara T; Kashihara D; Ichimura A; Kimura I; Tsujimoto G; Hirasawa A
Biochim Biophys Acta; 2014 Sep; 1841(9):1292-300. PubMed ID: 24923869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
